• Y-27632 Dihydrochloride: Applied Workflows in ROCK Inhibitio

  2026-07-27

  Unlock rigorous, reproducible cytoskeletal and cancer research with Y-27632 dihydrochloride, a selective ROCK inhibitor trusted for cell viability and invasion assays. This practical guide translates recent experimental evidence into actionable workflows and troubleshooting strategies, empowering researchers to maximize data quality and insight.

• Vemurafenib (PLX4032): Decoding Resistance in Melanoma Resea

  2026-07-26

  Explore how Vemurafenib (PLX4032) enables next-generation melanoma research by dissecting resistance networks and signaling rewiring, with a focus on recent multi-omics insights. This article offers advanced guidance for assay design and resistance modeling using Vemurafenib.

• Nanoplastic Exposure Disrupts Vascular Lipid Metabolism via

  2026-07-25

  This study demonstrates that prenatal and lactational exposure to polystyrene nanoplastics (PS-NPs) leads to lipid accumulation in vascular smooth muscle cells of male offspring, driven by the MAPK/ERK/UHRF1 signaling pathway. The findings provide mechanistic insight into how environmental nanoplastics exposure can affect early vascular health and highlight the utility of MEK inhibitors in dissecting these pathways.

• Hydroxytyrosol in Research: Protocol Precision & Workflow Ex

  2026-07-24

  Hydroxytyrosol, a potent 4-(2-hydroxyethyl)benzene-1,2-diol, is redefining cardiovascular and inflammation research with exceptional antioxidant reliability and workflow flexibility. This article delivers stepwise guidance, troubleshooting mastery, and cross-study optimization strategies—empowering research teams to achieve reproducible, high-impact results.

• AG-120 (Ivosidenib) Workflows: Precision in Mutant IDH1 AML

  2026-07-24

  AG-120 (Ivosidenib) empowers researchers to dissect metabolic rewiring and differentiation blockade in mutant IDH1 acute myeloid leukemia. This article delivers bench-tested workflows, troubleshooting strategies, and actionable insights for optimizing 2-hydroxyglutarate reduction and myeloid differentiation assays.

• Angiotensin II–HIF-1α-HILPDA Axis Drives Radioresistance in

  2026-07-23

  This study reveals that local angiotensin II suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma (NPC) via the HIF-1α-HILPDA axis. The mechanistic insights highlight therapeutic targets and biomarkers, proposing dual inhibition of Ang II signaling and ferroptosis modulation to enhance NPC radiosensitivity.

• GST Inhibition Reveals Mechanisms of Insecticide Resistance

  2026-07-23

  The reference study demonstrates that glutathione S-transferase (GST) activity is central to the resistance of Megalurothrips usitatus against the pyrethroid insecticide lambda-cyhalothrin. Inhibiting GST with diethyl maleate decreased antioxidant defenses and dramatically increased insecticide sensitivity, offering mechanistic insight for resistance management and oxidative stress modeling.

• Aromatase Inhibition by Lamotrigine: Impacts on Steroidogene

  2026-07-22

  This study systematically investigates how lamotrigine and other antiepileptic drugs inhibit the human aromatase enzyme (CYP19), a key regulator of sex hormone synthesis. The findings provide detailed evidence of lamotrigine’s moderate inhibitory effect, with implications for endocrine health in epilepsy treatment and experimental research.

• Applied Use-Cases of (S)-1-(3-fluoro-4-(trifluoromethoxy)phe

  2026-07-22

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) empowers researchers to dissect the Nrf2 signaling axis and osteoclast differentiation with high reproducibility. Its robust solubility and validated purity underpin advanced enzyme inhibition and redox studies in biochemical, cancer, and neuroscience research.

• UL84-FHL2 Axis in HCMV: Suppressing Interferon and Promoting

  2026-07-21

  Li et al. (2026) identify a novel immune evasion mechanism in human cytomegalovirus (HCMV), showing that the viral UL84 protein binds FHL2 to inhibit type I interferon (IFN-β) production and enhance viral replication. This discovery advances understanding of HCMV pathogenesis and opens avenues for targeting viral-host protein interactions.

• U0126: Selective MEK1/2 Inhibitor for MAPK/ERK Pathway Disse

  2026-07-21

  U0126 is a potent, selective MEK1/2 inhibitor used to dissect MAPK/ERK signaling in cellular models. It blocks MEK1/2 activity non-competitively, impacting downstream ERK1/2 phosphorylation and cellular fate. This article details its biological rationale, mechanism, evidence, and optimal research workflows.

• ERK5/MAPK Pathway in Vitamin D3-Induced AML Differentiation

  2026-07-20

  This study demonstrates that the ERK5/MAPK signaling pathway plays a critical and distinct role in mediating terminal differentiation of myeloid leukemia cells upon stimulation with 1α,25-(OH)2 vitamin D3. The findings reveal potential avenues for combinatorial therapies targeting MAPK sub-pathways in acute myeloid leukemia (AML), with implications for enhancing differentiation-based cancer treatments.

• Triptolide (PG490): Precision Tool for Translational Discove

  2026-07-20

  This thought-leadership article explores Triptolide (PG490) as a multifaceted molecular tool—delving into its mechanistic actions, translational impact, and strategic value for researchers in oncology, immunology, and developmental biology. Integrating foundational findings on genome activation and metastatic control, it provides actionable guidance on protocol design and positions Triptolide as an indispensable asset for high-precision experimental workflows.

• Ouabain as a Selective Na+/K+-ATPase Inhibitor: Mechanistic

  2026-07-19

  Discover how Ouabain, a selective Na+/K+-ATPase inhibitor, enables advanced mechanistic studies in ion transport and cardiac physiology. This article delivers original insight into assay design, translational research, and nuanced protocol optimization.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-07-18

  Phosbind Acrylamide transforms phosphorylation analysis by enabling high-resolution, antibody-free detection of protein phosphorylation states in SDS-PAGE workflows. Its unique phosphate-binding chemistry, optimal for the 30–130 kDa range, empowers signal transduction and kinase pathway studies with unmatched clarity and efficiency.

8608 records 4/574 page Previous Next 12345 下5页 Last page